Despite the sustained benefits for fluctuation/dyskinesia, axial motor symptoms, dementia, and psychiatric symptoms were important factors to decide the outcome from STN DBS in PD patients with SNCA mutations in our study. This evidence concerns the gene SNCA and Parkinson disease.